Related Attributes
Product details
Sulfadoxine Powder alias Sulfadoxine, Sulfadoxine, Sulfadoxine-o-methoxypyrimidine, Sulfadoxine Raw Materials is a white or off-white crystalline powder, Sulfadoxine CAS 2624-44-4 is generally used in the treatment of inflammation, such as upper respiratory infections, tonsillitis, dysentery, skin infections, etc. It can also be used in conjunction with other drugs to treat tuberculosis, lymphoma.
Sulfadoxine CAS 2624-44-4 is used in the treatment of inflammatory diseases, such as upper respiratory tract infections, tonsillitis, dysentery, enteritis, skin infections, etc. Sulfadoxine can also be used in combination with other drugs for the treatment of tuberculosis and lymphatic tuberculosis.
Uses and functions of Sulfadoxine Powder.
Sulfanilamide is generally used in the treatment of inflammatory diseases, such as upper respiratory tract infections, tonsillitis, dysentery, enteritis, skin infections, etc. It can also be used in conjunction with other medicines for the treatment of tuberculosis and lymphatic tuberculosis.
Pharmacological Effects of Sulfadoxine Powder.
Sulfadoxine (Sulphadoxine) is an ultra-long-acting sulfonamide that acts on P. Vivax with an IC50 of 249 μg/ml.
It is an ultra-long-acting sulphonamide used for the treatment of meningitis and urinary tract infections.
It is suitable for those who are allergic to penicillin G and erythromycin, and can treat respiratory tract infections, urinary tract infections, soft tissue infections, tonsillitis and bacillary dysentery. In addition, it is also effective for malaria, tuberculosis and leprosy.
Sulfanilamide has strong antibacterial activity against haemolytic streptococcus, pneumococcus, Shigella, Staphylococcus aureus, Escherichia coli, Escherichia coli, Pseudomonas aeruginosa and Salmonella. In addition, Sulfanilamide has antiplasmodial effect.
Production method of Sulfadoxine Powder.
Sulfanilamide is a systemic long-acting sulfonamide, a broad-spectrum antibacterial agent. The antibacterial mechanism of sulfadoxine is similar to that of other sulfonamides, and it can compete with amino benzoic acid (PABA) to act on dihydrofolate synthase in bacteria, thus preventing PABA from synthesising the tetrahydrofolate required by bacteria as raw material, and then inhibiting the synthesis of bacterial proteins and acting as an antibacterial agent.
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2022 Xi'an Henrikang Biotech Co., Ltd.,
Home
E-mail
Booking